Three days after Trump signed an executive order ending birthright citizenship for the children of parents without US citizenship or green cards ... from every kind of background.

Nigeria faces a household energy crisis. Approximately 127 million people and more than 24 million families cook inefficiently with open fires. Only one in... Wars and extreme weather conditions have ...

Howdy! Festival of the Arts is in full swing with a new Paint By Numbers mural, new pins were released, Living with the Land updates, and so much more fun in Disney’s Animal Kingdom and EPCOT. Good ...

National Coordinator, the Nigeria Reduced Emissions from Deforestation and Degradation (REDD ) Programme, Salisu Dahiru, has called on state governments in Nigeria to embrace... The African Union ...

Now, a little more than a year later, she’s making cuts of her own. The neuro-focused biotech is “making changes” to its research team to “reinvigorate the company's drug discovery ...

After reading a question asking the Patriots to consider joining the social media app, Kirsch provided background information ... the league gives us the green light we’ll get back on ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

In 2019, Stan­ford Uni­ver­si­ty pro­fes­sor Irv Weiss­man and a col­league pub­lished a pa­per that rep­re­sent­ed a new way to tar­get some ag­gres­sive can­cers.

A green screen is a tool used in filmmaking where a bright green background is digitally replaced with computer-generated imagery (CGI) or other footage during post-production. While common in modern ...

After raising questions surrounding dosing levels, the FDA has freed Amylyx’s early-stage amyotrophic lateral sclerosis (ALS) candidate from a clinical hold. When Amylyx had asked the FDA to ...

The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023. Moderna plans to move mRNA-1018 to a Phase 3 trial. Shares of Moderna (MRNA) took off Tuesday ...